Psychotic Disorders
📧 Sign up to get email alerts when something new happens for Psychotic Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis [NA]
A completed clinical trial comparing specialized addiction treatment versus treatment as usual for young patients with cannabis use disorder…
-
CLINICAL_TRIALS trial_result · 2011-01-10Clinical Trial Update: A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia. [Phase 3]
A Phase 3 study evaluated the safety and tolerability of switching from oral antipsychotics to a long-acting injectable form of risperidone …
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants [Phase 2, Phase 3]
An update on Phase 2 and Phase 3 trials evaluating whether omega-3 fatty acid EPA, combined with antioxidants, can treat schizophrenia and r…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia [Phase 3]
Phase 3 trial comparing long-acting injectable risperidone with placebo in schizophrenia reports effectiveness and safety data.
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
This document reports a completed post-authorization safety study (RiSPECT) evaluating the safety and effectiveness of risperidone used in r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-05-25Clinical Trial Update: Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting [Phase 4]
A Phase 4 clinical trial update examining how second-generation antipsychotics are used, and their effects and side effects, in real-world p…
-
CLINICAL_TRIALS trial_result · 2010-03-16Clinical Trial Update: Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia [Phase 4]
A Phase 4 study compared Risperdal Consta (risperidone long-acting injectable) to Abilify (aripiprazole) over two years in patients with sch…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment [Phase 1]
A completed Phase 1 clinical trial comparing specialized treatment versus unspecified treatment for individuals with dual diagnosis of psych…
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms [NA]
A completed Northwell Health trial evaluated a combination of an antidepressant and an antipsychotic for attenuated positive and negative sy…
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis [Phase 2]
A Phase 2 pilot study evaluating a modified cognitive behavioral therapy approach for adolescents with early onset psychosis.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: The Effects of Risperidone and Olanzapine on Thinking [Phase 4]
Phase 4 clinical trial update assessing the effects of risperidone and olanzapine on thinking/cognition in people with schizophrenia or psyc…
-
CLINICAL_TRIALS trial_result · 2008-11-26Clinical Trial Update: Pharmacy Interventions to Improve Chronic Disease Medication Refill [Phase 3]
Phase 3 clinical trial evaluating pharmacy interventions to improve chronic disease medication refills has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-25Clinical Trial Update: A Clinical Trial on the Antipsychotic Properties of Cannabidiol [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating the antipsychotic properties of cannabidiol in schizophrenia and…
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone [NA]
Pfizer-sponsored trial evaluating the differential sensitivity of two spatial working memory tests in individuals with schizophrenia treated…
-
CLINICAL_TRIALS trial_result · 2008-06-04Clinical Trial Update: Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine [Phase 4]
Phase 4 clinical trial evaluating duloxetine for major depressive episodes occurring during psychotic disorders has completed, assessing its…
-
CLINICAL_TRIALS trial_result · 2008-03-31Clinical Trial Update: Safety Study of ORG 34517 for Major Depression With Psychotic Features [Phase 2]
A Phase 2 safety study evaluating ORG 34517 for major depressive disorder with psychotic features has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: New Drugs in the Treatment of Mood Disorders [Phase 2]
Phase 2 clinical trial update reporting completion of trials investigating new drugs for mood disorders.
-
CLINICAL_TRIALS trial_result · 2007-04-03Clinical Trial Update: Rapid Tranquillization Trial: TREC-India II [Phase 3]
Phase 3 rapid tranquilization trial (TREC-India II) in psychotic disorders with aggression has completed. The status shown is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: A Comparative Study of New Medications for Psychosis in Adolescents [NA]
This clinical trial update reports the completion of a comparative study evaluating new medications for psychosis in adolescents. The study …